Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations

Behavioral sensitization to psychomotor stimulants is accompanied by a number of alterations in the mesoaccumbens dopamine (DA) system, including DA autoreceptor subsensitivity in the ventral tegmental area (VTA) and DA D1 receptor supersensitivity in the nucleus accumbens (NAc). We investigated the role of excitatory amino acid (EAA) transmission in the induction of cocaine sensitization and these accompanying DA receptor alterations. To do so, we used three glutamate receptor antagonists, the noncompetitive NMDA receptor antagonist MK‐801 (0.1 mg/kg), the competitive NMDA receptor antagonist CGS 19755 (10.0 mg/kg), and the AMPA receptor antagonist NBQX (12.5 mg/kg). Rats received daily double injections of either one of these antagonists or saline with either cocaine (15.0 mg/kg) or saline for 5 days. Cocaine sensitization was defined as an increase in horizontal locomotor activity in response to cocaine challenge (7.5 mg/kg) on the third day of withdrawal. All three antagonists prevented the induction of cocaine sensitization. Extracellular single cell recordings revealed that these antagonists also prevented the induction of DA autoreceptor subsensitivity in the VTA and DA D1 receptor supersensitivity in the NAc. To determine whether the relevant glutamate receptors were under regulation by medial prefrontal cortex (mPFC) EAA efferents, we next lesioned the mPFC bilaterally with ibotenic acid at least 7 days before repeated cocaine treatment began. These lesions also prevented the induction of cocaine sensitization and the associated neuroadaptations. Our findings indicate that glutamate transmission from mPFC to the mesoaccumbens DA system is critical for the induction of cocaine sensitization and its cellular correlates. Synapse 34:169–180, 1999. © 1999 Wiley‐Liss, Inc.

[1]  F. J. White,et al.  Dopamine Receptor Antagonists Fail to Prevent Induction of Cocaine Sensitization , 1998, Neuropsychopharmacology.

[2]  P. Vezina,et al.  Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects , 1990, Brain Research.

[3]  P. Kalivas,et al.  Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine , 1997, Neuroscience.

[4]  N Clerc,et al.  Intrinsic primary afferent neuronsof the intestine , 1998, Progress in Neurobiology.

[5]  L. Stinus,et al.  Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine , 1995, Neuroscience.

[6]  J. Steketee,et al.  Repeated injection of GBR 12909, but not cocaine or WIN 35,065-2, into the ventral tegmental area induces behavioral sensitization , 1998, Behavioural Brain Research.

[7]  S. Cunningham,et al.  Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  F. J. White,et al.  Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronicd-amphetamine treatment , 1984, Brain Research.

[9]  P. Kalivas,et al.  Robustness of G protein changes in cocaine sensitization shown with immunoblotting , 1993, Synapse.

[10]  S. Shibata,et al.  NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release. , 1996, The Journal of pharmacology and experimental therapeutics.

[11]  P Duffy,et al.  Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  A E Kelley,et al.  Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  P. Kalivas,et al.  Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex , 1993, Neuroscience.

[14]  P. Vezina,et al.  Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. , 1994, The Journal of pharmacology and experimental therapeutics.

[15]  F. J. White,et al.  Synaptic regulation of mesocorticolimbic dopamine neurons. , 1996, Annual review of neuroscience.

[16]  M. Wolf,et al.  The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants , 1998, Progress in Neurobiology.

[17]  P. Kalivas,et al.  Neuroadaptations in Ionotropic and Metabotropic Glutamate Receptor mRNA Produced by Cocaine Treatment , 1999, Journal of neurochemistry.

[18]  N. Goeders,et al.  Cortical dopaminergic involvement in cocaine reinforcement. , 1983, Science.

[19]  M. Wolf,et al.  Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine , 1991, Brain Research.

[20]  M. Wolf,et al.  Amphetamine and D1 Dopamine Receptor Agonists Produce Biphasic Effects on Glutamate Efflux in Rat Ventral Tegmental Area: Modification by Repeated Amphetamine Administration , 1998, Journal of neurochemistry.

[21]  F. J. White,et al.  Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. , 1995, The Journal of pharmacology and experimental therapeutics.

[22]  A. Bonci,et al.  A Common Mechanism Mediates Long-Term Changes in Synaptic Transmission after Chronic Cocaine and Morphine , 1996, Neuron.

[23]  F. J. White,et al.  Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. , 1991, The Journal of pharmacology and experimental therapeutics.

[24]  S. Amir,et al.  Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine , 1994, Brain Research.

[25]  D J Henry,et al.  Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. , 1989, The Journal of pharmacology and experimental therapeutics.

[26]  M. Wolf,et al.  Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization , 1993, Brain Research.

[27]  P. Kalivas,et al.  Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens , 1987, Brain Research.

[28]  D. Henry,et al.  The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  P. Vezina,et al.  The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine , 1989, Brain Research.

[30]  R. Karler,et al.  The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine , 1997, Brain Research.

[31]  J. MacDonall,et al.  Effects of nitric oxide synthase inhibitors on cocaine sensitization , 1997, Brain Research.

[32]  H. Davis,et al.  Prevention of denervation atrophy in muscle: Mammalian neurotrophic factor is not transferrin , 1984, Brain Research.

[33]  R. Wyatt,et al.  Chronic cocaine administration increases tyrosine hydroxylase activity in the ventral tegmental area through glutaminergic- and dopaminergic D2-receptor mechanisms , 1996, Neuroscience Letters.

[34]  P. Calabresi,et al.  Long-term synaptic depression in the striatum: physiological and pharmacological characterization , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  S. Sesack,et al.  Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area , 1992, The Journal of comparative neurology.

[36]  D. L. Davidson,et al.  Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. , 1997, The Journal of pharmacology and experimental therapeutics.

[37]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[38]  P. Kalivas,et al.  Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. , 1993, The Journal of pharmacology and experimental therapeutics.

[39]  K. Berridge,et al.  The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.

[40]  P. Overton,et al.  Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat , 1995, Brain Research.

[41]  S. Young,et al.  Glutamate-dependent long-term presynaptic changes in corticostriatal excitability , 1996, Neuroscience.

[42]  H. Kuribara,et al.  Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice. , 1995, Japanese journal of pharmacology.

[43]  T. Ohmori,et al.  Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine , 1995, Brain Research.

[44]  R. Roth,et al.  R-(+)-HA-966, an antagonist for the glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures , 1995, Brain Research.

[45]  Y. Itzhak Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. , 1997, The Journal of pharmacology and experimental therapeutics.

[46]  M. Wolf,et al.  Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex , 1997, Synapse.

[47]  S. Dworkin,et al.  Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex , 1986, Pharmacology Biochemistry and Behavior.

[48]  W. Park,et al.  Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. , 1995, The Journal of pharmacology and experimental therapeutics.

[49]  H. Kuribara Modification of cocaine sensitization by dopamine D1 and D2 receptor antagonists in terms of ambulation in mice , 1995, Pharmacology Biochemistry and Behavior.

[50]  E. Nestler,et al.  Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[51]  X.-T. Hu,et al.  MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  P. Kalivas,et al.  D1 receptors modulate glutamate transmission in the ventral tegmental area , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  M. Le Moal,et al.  Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. , 1996, The Journal of pharmacology and experimental therapeutics.

[54]  J. Meador-Woodruff,et al.  Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems , 1996, Brain Research.

[55]  M. Shoaib,et al.  Neuroanatomical localization of the effects of (+)-HA966 on locomotor activity after cocaine injections to the nucleus accumbens of rats , 1996, Brain Research.

[56]  P. Kalivas,et al.  Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. , 1988, The Journal of pharmacology and experimental therapeutics.

[57]  M. Wolf,et al.  Acute and Repeated Systemic Amphetamine Administration: Effects on Extracellular Glutamate, Aspartate, and Serine Levels in Rat Ventral Tegmental Area and Nucleus Accumbens , 1996, Journal of neurochemistry.

[58]  J. V. van Rossum,et al.  Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. , 1976, European journal of pharmacology.

[59]  R. Malenka,et al.  Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens , 1994, Nature.

[60]  F. J. White,et al.  Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. , 1993, Behavioural pharmacology.

[61]  P. Vezina,et al.  D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[62]  S. Goldberg,et al.  Behavioral studies with the glycine partial agonist (+)‐HA966 on cocaine‐induced locomotor activity and reinforcement , 1995, Behavioural pharmacology.

[63]  F. J. White,et al.  Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. , 1997, The Journal of pharmacology and experimental therapeutics.

[64]  H. Kuribara,et al.  Dopamine Antagonists Can Inhibit Methamphetamine Sensitization, But Not Cocaine Sensitization, When Assessed by Ambulatory Activity in Mice , 1993, The Journal of pharmacy and pharmacology.

[65]  F. J. White,et al.  Whole-Cell Plasticity in Cocaine Withdrawal: Reduced Sodium Currents in Nucleus Accumbens Neurons , 1998, The Journal of Neuroscience.

[66]  M. Wolf,et al.  Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex , 1999, Synapse.

[67]  N. Hiroi,et al.  Regulation of ERK ( Extracellular Signal Regulated Kinase), Part of the Neurotrophin Signal Transduction Cascade, in the Rat Mesolimbic Dopamine System by Chronic Exposure to Morphine or Cocaine , 1996, The Journal of Neuroscience.

[68]  E. Nestler,et al.  Identification of MARPP-58, a morphine- and cyclic AMP-regulated phosphoprotein of 58 kDa, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[69]  Yong Li,et al.  Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine , 1997, Psychopharmacology.

[70]  F. J. White,et al.  A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment , 1990, Neuroscience Letters.

[71]  P. Kalivas,et al.  Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. , 1996, The Journal of pharmacology and experimental therapeutics.

[72]  M. Wolf,et al.  Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine , 1997, Behavioural Brain Research.

[73]  R. Roth,et al.  Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract‐tracing study with Phaseolus vulgaris leucoagglutinin , 1989, The Journal of comparative neurology.

[74]  E. Nestler,et al.  Chronic Cocaine Treatment Decreases Levels of the G Protein Subunits Giα and Goα in Discrete Regions of Rat Brain , 1990 .

[75]  B. Mattingly,et al.  Cocaine-induced behavioral sensitization: Effects of haloperidol and SCH 23390 treatments , 1996, Pharmacology, Biochemistry and Behavior.

[76]  M. Wolf,et al.  Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: Comparison with N-methyl-d-aspartate antagonists , 1995, Neuroscience.

[77]  S. A. Turkanis,et al.  Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. , 1989, Life sciences.

[78]  N. Uretsky,et al.  Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens , 1989, Neuropharmacology.

[79]  S. Schenk,et al.  Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus , 1994, Brain Research.

[80]  J. MacDonall,et al.  Antagonist of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization. , 1995, Life sciences.

[81]  J. B. Justice,et al.  Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions , 1992, Pharmacology Biochemistry and Behavior.

[82]  M. Bozarth,et al.  L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. , 1993, Life sciences.

[83]  F. J. White,et al.  MK‐801 prevents the development of behavioral sensitization during repeated morphine administration , 1994, Synapse.